E1A expression dysregulates IL-8 production and suppresses IL-6 production by lung epithelial cells by van den Berg, Arjen et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
Respiratory Research
Open Access Research
E1A expression dysregulates IL-8 production and suppresses IL-6 
production by lung epithelial cells
Arjen van den Berg*1,2, Mieke Snoek1,2, Henk M Jansen1 and René Lutter1,2
Address: 1Department of Pulmonology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands and 2Department of 
Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Email: Arjen van den Berg* - a.vandenberg@amc.uva.nl; Mieke Snoek - m.snoek@amc.uva.nl; Henk M Jansen - h.m.jansen@amc.uva.nl; 
René Lutter - R.Lutter@amc.uva.nl
* Corresponding author    
Abstract
Background: The adenoviral protein E1A has been proposed to play a role in the pathophysiology
of COPD, in particular by increasing IL-8 gene transcription of lung epithelial cells in response to
cigarette smoke-constituents suc h  a s  L P S .  A s  I L - 8  p r o d u c t i o n  i s  a l s o  u n d e r  t i g h t  p o s t -
transcriptional control, we planned to study whether E1A affected IL-8 production post-
transcriptionally. The production of IL-6 by E1A-positive cells had not been addressed and was
studied in parallel. Based on our previous work into the regulation of IL-8 and IL-6 production in
airway epithelial cells, we used the lung epithelial-like cell line NCI-H292 to generate stable
transfectants expressing either E1A and/or E1B, which is known to frequently co-integrate with
E1A. We analyzed IL-8 and IL-6 production and the underlying regulatory processes in response to
LPS and TNF-α.
Methods: Stable transfectants were generated and characterized with immunohistochemistry,
western blot and flow cytometry. IL-8 and IL-6 protein production was measured by ELISA. Levels
of IL-8 and IL-6 mRNA were measured using specific radiolabeled probes. EMSA was used to assess
transcriptional activation of relevant transcription factors. Post-transcriptional regulation of mRNA
half-life was measured by Actinomycin D chase experiments.
Results: Most of the sixteen E1A-expressing transfectants showed suppression of IL-6 production,
indicative of biologically active E1A. Significant but no uniform effects on IL-8 production, nor on
transcriptional and post-transcriptional regulation of IL-8 production, were observed in the panel
of E1A-expressing transfectants. E1B expression exerted similar effects as E1A on IL-8 production.
Conclusion: Our results indicate that integration of adenoviral DNA and expression of E1A and
E1B can either increase or decrease IL-8 production. Furthermore, we conclude that expression
of E1A suppresses IL-6 production. These findings question the unique role of E1A protein in the
pathophysiology of COPD, but do not exclude a role for adenoviral E1A/E1B DNA in modulating
inflammatory responses nor in the pathogenesis of COPD.
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Background
Chronic obstructive pulmonary disease (COPD) is charac-
terized by chronic inflammation and irreversible airflow
obstruction [1], and is associated with cigarette smoking.
Not all smokers, however, develop COPD. Hogg and co-
workers have put forward the concept that the presence of
the adenoviral E1A DNA and protein in airway structural
cells, leading to enhanced IL-8 production in response to
endotoxin exposure, may be related to the development
of COPD. First they showed by PCR analysis that lung tis-
sue from COPD patients contained more E1A DNA than
lung tissue from matched non-COPD smokers [2]. Subse-
quently, and in line with the presence of E1A DNA, E1A
protein was found to be expressed in airway and alveolar
epithelial cells from COPD patients [3]. Based on the
model of genomic integration of adenoviral DNA pro-
posed by Graham [4], it is likely that a second early aden-
oviral gene, E1B, is also integrated and possibly expressed,
but this was not investigated. As E1A interacts with a large
number of regulatory proteins and as epithelial cells
express inflammatory proteins, it was postulated that E1A
protein modifies the expression of these inflammatory
proteins. Stable E1A transfectants of alveolar type-II-like
A549 cells indeed showed increased IL-8 [5] and ICAM-1
[6] expression specifically in response to LPS, which is a
major constituent of cigarette smoke. Similar results were
obtained with E1A-transformed bronchial epithelial cells
transfected with both the E1A and E1B gene [7]. The in
vivo relevance of E1A expression was illustrated with a
guinea pig model, showing an enhanced inflammatory
response to cigarette smoke in animals with lung tissue
containing E1A DNA [8].
The increased in vitro production of IL-8 and ICAM-1 by
E1A transfectants to LPS appeared to be dependent on an
enhanced transcriptional activity, involving activation of
NFκB [5,7]. Our previous studies into the regulation of IL-
8 and IL-6 production by lung epithelial-like NCI-H292
cells indicated that, besides transcriptional regulation
through NFκB, AP-1 and C/EBP activation, post-transcrip-
tional regulation, exemplified by a modified mRNA deg-
radation, was a major means of regulating IL-8 and IL-6
responses [9-11]. Similar findings were obtained with
another lung epithelial cell line, Calu-3 cells, as well as
primary bronchial epithelial cells. In fact, lung epithelial
cells with a decreased rate of mRNA degradation dis-
played hyperresponsive IL-8 and IL-6 production, similar
to that observed for E1A-expressing A549 cells [5]. There-
fore, we hypothesized that, expression of E1A in lung epi-
thelial-like cells may lead to stabilization of IL-8 mRNA
paralleled by increased IL-8 production in response to LPS
and to TNF-α. In parallel, we analyzed IL-6 production,
which was anticipated to be decreased, as E1A is known to
inhibit IL-6 transcription [13].
To investigate this, we generated stable transfectants of
NCI-H292 cells expressing E1A. As the E1B gene is fre-
quently co-integrated with that of E1A, and as E1B protein
modifies E1A functions, we also generated stable E1A-
and E1B-transfectants. Stable transfectants of E1B and of
the empty vector expressing green fluorescent protein
(GFP)-tagged zeocin-resistance protein served as controls.
Materials and methods
Constructs
In order to construct pTracerSV40-ZeocinGFP vectors
(Invitrogen, Paisley, UK) expressing E1A, E1B, or both
proteins, pAt153-Xho [14] (a kind gift from Dr. Robert
Vries, LUMC, Department of Molecular Cell Biology, Lei-
den, The Netherlands), containing the first 5789 bp of the
Ad5 genome was used as donor construct. To construct
the vector pTracer-E1A, containing E1A only, pAt153-xho
was digested with Sst1 and the 7K fragment, containing
E1A and vector sequence, was isolated and ends were
blunted with T4 DNA polymerase. Subsequently this frag-
ment was digested with EcoR1 and the 1774 bp fragment
was isolated and ligated into EcoR1/EcoRV digested
pTracer-SV40.
To construct the pTracer-E1B, containing only E1B (both
19K- and 55K-E1B proteins), pAt153-Xho was digested
with HPA1 and APA1 and the isolated fragment was
ligated into pTracer-SV40. The vector pTtracer-E1AB was
constructed by digestion of pAt153-Xho with EcoR1 and
APA1 and subsequent ligation.
All constructs were verified by sequencing (BigDye
sequencing kit, ABI, Foster City, CA) and restriction
analysis.
Generation of stable clones
Human lung mucoepidermoid carcinoma derived NCI-
H292 cells (CRL 1848; American Type Culture Collection
(ATCC), Manassas, VA) were grown to 90% confluency in
a 75 cm2 culture flask, as described before [11]. Before
transfection, growth medium was replaced with 10 ml
medium without penicillin and streptomycin. Twenty-
five  µg of vector DNA was mixed with 60 µl of Lipo-
fectamine 2000 (Invitrogen) in a volume of 3 ml Opti-
mem-1 (Invitrogen) and layered onto NCI-H292 cells
resulting in 20–30% GFP-positive cells after 24 h. Stable
clones were obtained by selection in medium containing
100 µg/ml Zeocin (Invitrogen), of which 250 µl/well was
plated in 48-wells plates at a concentration of 6 cells/ml.
Medium was replaced twice a week. After formation of
colonies, screening of clones was initially performed by
immunohistochemistry in 96-well plates. Clones positive
for E1A or E1B were selected and expression of E1A or E1B
was confirmed by Western blot. Clones negative for E1A
or E1B as determined by immunohistochemistry wereRespiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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discontinued. Monoclonality of clones was tested by flow-
cytometry analyzing both GFP and E1A.
Cell culture
Clones were cultured and propagated as described before
for NCI-H292 cells [11], with the exception that 100 µg/
ml Zeocin was added to the medium. Before experiments,
cells were cultured one week without Zeocin, and all
experiments were performed in Zeocin-free medium.
For cytokine release, 6 × 105 cells were plated and grown
overnight in 500 µl in 24-well plates. For isolation of
mRNA and nuclear extracts, 30 × 105 cells were plated and
grown overnight in 2.5 ml in 6-well plates.
Immunohistochemistry
Cells were fixed with 4% (v/v) paraformaldehyde/0.1%
(w/v) Saponin and subsequently incubated with ice-cold
methanol for 1 min. To prevent non-specific signals, cells
were incubated for 1 h with 5% (w/v) BSA containing
0.1% (w/v) sodiumazide and 0.1% (v/v) H2O2 and 0.1%
Saponin. Then, the cells were incubated with primary
antibody (M73 (Santa Cruz Biotechnologies, Santa Cruz,
CA) for E1A, 1G11 for E1B-19K or 9C10 E1B-55K [15],
both kind gifts from Dr. Robert Vries (LUMC, Leiden,
Netherlands) diluted 1:500 in PBS/0.5%BSA/0.1%
Saponin (PBSAP) overnight at 4°C. Next, cells were
washed 3× with PBS/0.1% Saponin and incubated with
1:250 biotinylated goat-anti-mouse-IgG in PBSAP (Dako-
Cytomation Glostrup, Denmark) for 1 h followed by 3
wash steps. Finally, cells were incubated with Streptavi-
din-Horseradish Peroxidase (HRP, DakoCytomation)
(1:250 in PBSAP) for 30 min, washed and developed with
AEC staining solution (Vector Laboratories, Burlingame,
CA).
E1A FACS
Cells were trypsinized and fixed with 4% paraformalde-
hyde/0.1% Saponin. To prevent aspecific binding, cells
were incubated for 30 min with PBS/5% BSA/0.1%
Saponin. Then, cells were incubated with the primary
antibody M73 (1:500 in PBSAP) for 30 min and subse-
quently with biotinylated goat anti-mouse IgG (1:250 in
PBSAP) for 30 min. Next, cells were labeled with Strepta-
vidin-Allophycocyanin (DakoCytomation, 1:100 in
PBSAP) and analyzed by a FACSCalibur flow cytometer
and CellQuest Pro software (BD Biosciences). All incuba-
tions were performed at RT on a shaking platform.
Between incubations, cells were washed twice with
PBSAP.
Western blot
Lysates were prepared by scraping cells (± 5 × 106) in lysis
buffer (1% (w/v) NP40, 10 mM Tris-HCl pH 7.4, 150 mM
NaCl, 5 mM EDTA, 1 mM phenylmethylsulphonyl-fluo-
ride (PMSF)). Lysates were cleared by centrifugation at
13,000 g for 15 min. Protein contents in cell lysates were
determined using Coomassie Plus protein assay reagent
(Pierce, Rockford, IL, USA). Fifty µg of protein/lane was
separated by SDS-PAGE under reducing conditions. After
transfer to nitrocellulose (Hybond-C, Amersham, Buck-
inghamshire, UK), blots were blocked with 5% (w/v)
non-fat dry milk in TBST (10 mM Tris, 150 mM NaCl and
0.05% (v/v) Tween-20, pH 8.0), and were probed over-
night at 4°C with M73 antibody 1:1000 diluted in TBST
containing 2.5% non-fat dry milk. Immunoreactive pro-
teins were visualized using HRP-conjugated Ig (Goat-anti-
mouse for M73 and 9C10 or Goat-anti-Rat for 1G11) and
enhanced chemiluminescence (ECL, Amersham).
Determination of IL-6 and IL-8 protein
Cells were exposed for 8 h to various doses of TNF-α
(rhTNF-α, R&D Systems, Minneapolis, MN, USA) or LPS
derived from E.Coli  K-235 (L2018, Sigma-Aldrich, St.
Louis, MO) up to 5 ng/ml and 1 µg, respectively. The
amount of IL-6 and IL-8 in culture supernatants was meas-
ured by sandwich ELISA, as described before [9,12].
mRNA half-life analysis
Cells were stimulated with TNF-α (5 ng/ml) or LPS (0.1
µg/ml) for one hour before 5 µg/ml actinomycin D
(Sigma-Aldrich) was added to block further transcription.
Total RNA was extracted with TriZol (Invitrogen) at 0, 40
and 80 minutes after Actinomycin D addition. The
amount of IL-6, IL-8 and GAPDH mRNA was determined
by dotblotting and hybridization with specific 32P-labeled
probes for IL-6, IL-8 and GAPDH, which have been exten-
sively validated for specificity in our samples by Northern
blot as described [10,11]. Blots were quantified using a
phosphorimager and variable loading was corrected for
by expressing mRNA levels relative to that of the house-
keeping gene GAPDH. mRNA half-life was calculated
using linear regression.
Isolation of nuclear extracts and electrophoretic mobility 
shift assay (EMSA)
Nuclear extracts were isolated after 1 h stimulation with 5
ng/ml TNF-α and 0.1 µg LPS as described [10,11]. Protein
concentrations were measured as described above. Five µg
of the nuclear extracts were incubated with 32P-labeled
oligonucleotides at 4°C for 1 h and separated on a 4%
non-reducing poly-acrylamide gel at slowly increasing
voltages (60–220 V). Bands were identified by supershift
using 1 µg of antibodies against p65 for NF-κB, c-fos and
c-jun for AP-1, and C/EBP-β for C/EBP (Santa Cruz Bio-
technology Inc., Santa Cruz, CA) and by competition with
cold probe. The intensity of the bands was quantified
using a phosphorimager. The following oligonucleotides
were used in the EMSA:Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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NF-κB, 5'-TTGCAAATCGTGGAATTTCCTCTGACATAA-3';
AP-1, 5'-TTAAGTGTGATGACTCAGGTTTAA-3';
C/EBP, 5'-TTAAAGGACGTCACATTGCACAATCTTAATAA-
3'.
Construction of siRNA
siRNAs directed against both 12S and 13S E1A mRNA
were designed using the Ambion siRNA target finder
http://www.ambion.com/techlib/misc/
siRNA_finder.html using accession code AY147066.
The following sequences were selected:
AACTGTATGATTTAGACGTGA (Start position in
sequence: 134)
AAGTGAAAATTATGGGCAGTG (Start position in
sequence: 599)
AATGCAATAGTAGTACGGATA (Start position in
sequence: 671)
AATTTTTACAGTTTTGTGGTT (Start position in sequence:
660)
AATGTATCGAGGACTTGCTTA (Start position in
sequence: 800)
AAGATCCCAACGAGGAGGCGG (Start position in
sequence: 723, published in [16])
Oligonucleotides were then designed using the Ambion
siRNA Template Design Tool http://www.ambion.com/
techlib/misc/silencer_siRNA_template.html. siRNAs were
constructed with the Silencer™ siRNA Construction Kit
(Ambion, Austin, TX) according to the manufacturer's
instructions. As a control for proper synthesis and trans-
fection efficiency, the GAPDH siRNA template included in
the kit was used. One to 10 pmol of siRNA was mixed with
0.5 µl Lipofectamine 2000 (Invitrogen) in 50 µl Opti-
mem-1 medium (Invitrogen) according to the manufac-
turer's instructions and transferred to a well of a 48-wells
plate with cells at 30–50% confluency. Assessment of
gene silencing was performed 24- or 48 post-transfection
by PCR and immunohistochemistry.
E1A and GAPDH PCR
Single strand cDNA was synthesized from total RNA iso-
lated with Trizol (Invitrogen) using 500 ng of oligo(dT)15
and 100 units of Superscript II (Gibco/Brl) in a 50 µl vol-
ume. One µl of cDNA was used in the PCR reaction (50
mM KCl, 2 mM MgCl2, 10 mM Tris-HCl (pH 9.0) 200 mM
of each dNTP, 0.1% Triton X-100, 200 nM of each primer
and 1.25 U of Taq DNA polymerase (Promega, Madison,
WI)). For E1A, the PCR conditions were 30 thermal cycles
at 94°C for 1 min, 59°C for 1 min and 72°C for 1 min,
followed by a final extension at 72°C for 10 min. The fol-
lowing primers were designed using primer 3 http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi and
accession code X02996:
5'-GTGACGACGAGGATGAAGA-3' (bp 395–413);
5'-ACGGCAACTGGTTTAATGG-3' (bp 614–632).
This primer set produces a 238 bp product for 12S E1A
mRNA and a 375 bp product for 13S E1A mRNA.
Unspliced E1A mRNA yields a 495 bp product.
For GAPDH, the PCR conditions were 25 thermal cycles at
94°C for 1 min, 55°C for 1 min and 72°C for 1 min, fol-
lowed by a final extension at 72°C for 10 min. The follow-
ing primers were designed using primer 3 and accession
code NM_002046:
5'-ATGAAGGTCGGAGTCAACG-3' (bp 86–103);
5'-TGAAGACGCCAGTGGACTC-3' (bp 364–382):
This primer set produces a 296 bp product.
Results
Generation of stable transfectants and expression of 
target proteins
Constructs of E1A, E1B and E1A plus E1B in the
pTracerSV40-Zeo vector were used to generate stable
transfectants of NCI-H292 cells. Over 150 zeocin-resistant
GFP-positive clones transfected with the E1A construct
were generated, but none of these clones expressed E1A at
a level detectable by immunohistochemistry (IHC). As
expression of E1A leads to apoptosis in non-ras-trans-
formed cells [17,18], it is likely that NCI-H292 cells
expressing E1A protein underwent apoptosis. Transfec-
tion with E1A plus E1B yielded 144 zeocin-resistant
clones, 6 of which (designated AB-clones) were found to
express E1A by IHC (Fig 1A). Western blot showed that
both E1A gene products, the 289R and 243R E1A, were
expressed at equal levels (Fig 1B). The E1A-positive clones
expressed low levels of either 19K or 55K E1B by Western
blot which was not detectable by IHC. Transfection with
the E1B construct yielded 30 zeocin-resistant clones, 6 of
which (designated B-clones) were positive for the 55K
E1B protein as determined by IHC. As controls, we gener-
ated 7 stable transfectants with the empty vector express-
ing GFP (designated T clones).Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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Effect of E1A expression on IL-8 and IL-6 secretion in 
response to LPS and TNF-α
We next evaluated the TNF-α- and LPS-induced IL-8 and
IL-6 responses of the various clones. Hyperresponsive and
hyporesponsive clones are defined respectively as clones
with a significant (p < 0.05) 2.5-fold increased or 2.5-fold
decreased (i.e. 0.4 times) IL-8 or IL-6 production relative
to the mean of the control (T) clones, for all tested doses
of a stimulus. Normoresponsive clones are those that stay
within this 2.5-fold range. This definition is based on the
observation of Hogg and coworkers, who showed at least
a 2.5-fold increase in IL-8 production in response to 0.01
µg/ml LPS for an E1A-positive clone compared to an E1A-
negative clone [5].
Of the 6 AB clones tested, 2 clones (AB38 and AB96)
showed a hyperresponsive IL-8 production in response to
both LPS and TNF-α, whereas the other 4 did not (Fig 2,
Table 1). One B-clone (B1) was hyperresponsive to TNF-α
but not to LPS, whereas two B-clones (B3 and B4) were
hyporesponsive to both TNF-α and LPS. With respect to
IL-6, none of the tested clones displayed a hyperrespon-
sive IL-6 production in response to LPS or TNF-α (Fig 3,
Table 1). In fact, one AB clone (AB157), and two B clones
(B4 and B5) displayed hyporesponsive IL-6 production to
LPS. All AB clones except AB38 showed hyporesponsive
IL-6 production to TNF-α (Fig 3B, Table 1), and the same
two B clones (B4 and B5) that had a hyporesponsive IL-6
production to LPS also displayed a hyporesponsive IL-6
production to TNF-α.
Analysis of transcriptional activation by EMSA
Our previous studies showed that TNF-α- and LPS-
induced transcription of IL-8 in NCI-H292 cells is
dependent mainly on the transcription factor NFκB and to
a lesser extent on AP-1 [11]. We compared activation of
NFκB in both AB clones with a hyperresponsive IL-8 pro-
duction to LPS (AB96 and AB38) to that of a normore-
sponsive AB-clone (AB66), a T-clone (T4) and a B-clone
(B3) (Fig. 4A). We found no further upregulation of NFκB
activation by E1A expression. Similar findings were
observed upon stimulation with TNF-α. (Fig 4B).
We also determined nuclear recruitment of transcription
factors AP-1 and C/EBP; the latter is involved in regulation
E1A expression in AB clones Figure 1
E1A expression in AB clones. IHC for clone AB96 and for other AB clones demonstrated a strict nuclear localization of 
expressed E1A (A, left panel) in E1A-positive clones. The right panel is stained with a control IgG (200 fold magnification). 
Expression of E1A by AB clones was confirmed by Western blot (B), with HEK293 cells as positive control. Please note the 
equal expression of both the 289R- and the 243R-E1A proteins.Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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IL-8 production by various clones in response to exposure to LPS and TNF-α Figure 2
IL-8 production by various clones in response to exposure to LPS and TNF-α. Equal cell numbers from clones were 
exposed to a concentration range of LPS (see z-axis; 0–1 µg/ml, A) or TNF-α (0–5 ng/ml, B) for 8 hrs. IL-8 in culture superna-
tant was measured by ELISA. T represents the mean IL-8 production (in pg/ml; y-axis) of 7 T-clones. Individual B and AB clones 
as designated on the x-axis. Data are shown as the mean of two independent experiments (triplicate samples). Due to the rep-
resentation as a 3D-matrix, no standard deviation can be shown. Asterisks indicates significant (* = p < 0.05, ** = p < 0.01, *** 
= p < 0.001) hyperresponsiveness, # indicates significant hyporesponsiveness (# = p < 0.05, ## = p < 0.01, ### = p < 0.001).
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of IL-6 gene transcription in NCI-H292 cells [10]. Again,
we found no altered upregulation of AP-1 or C/EBP
recruitment in E1A-expressing clones to either TNF-α or
LPS (data not shown).
Analysis of IL-8 and IL-6 mRNA half-life
An increased half-life of IL-8 and IL-6 mRNA can be
accompanied by an enhanced production of these
cytokines [9,12]. Therefore, we tested whether the differ-
ence in responsiveness to TNF-α and LPS of the clones was
paralleled by alterations in the half-life of IL-8- and IL-6
mRNA. One hyperresponsive AB clone (AB96) tended to
have an increased half-life of IL-8 mRNA compared to the
normoresponsive T clones (p= 0.06). However, the nor-
moresponsive clone B6 had a similarly increased IL-8
mRNA half-life (Fig. 5A). Moreover, clone AB96, that dis-
played hyporesponsive IL-6 production, had a relative sta-
ble IL-6 mRNA (Fig. 5B). Similar heterogeneous results
emerged when clones were stimulated with LPS (data not
shown), and thus differences in responsiveness between
the various clones did not parallel changes in the half-life
of IL-8 and IL-6 mRNA.
Responses of E1A- and E1B-expressing NCI-H292 
subclones
Together, these data indicated that expression of biologi-
cally active E1A did not correlate with an enhanced IL-8
production, nor did E1A expression uniformly affect
mechanisms regulating IL-8 production. For IL-6, there
was a similar heterogeneity, but E1A expression appeared
to inversely correlate with IL-6 production. To exclude
that the observed heterogeneity in responses was due
solely to an intrinsic heterogeneity of the mother cell line,
we subcloned NCI-H292 cells and tested IL-6 responses to
TNF-α of 15 subclones. We found up to a 15-fold differ-
ence in maximal IL-6 responses between clones (this
response range is calculated by dividing the maximal
response by the minimal response at 5 ng/ml TNF-α for a
group of clones; data not shown), which is similar to that
for the T-clones (11-fold difference), but less than that for
B- and AB-clones, 30- and 40-fold difference, respectively.
This suggests that the larger response range in AB- and B-
clones is caused by the presence of E1A and E1B DNA,
although part of the response range appears due to biolog-
ical variation of the motherline and/or results from the
procedure of subcloning. To further test the latter we
cloned an earlier derived subclone and tested TNF-α- and
LPS-induced responses from 11 derived sub-subclones.
This time, we found a 4-fold difference between clones in
their maximal IL-6 and also IL-8 responses, which indi-
cates that there is some variation in the NCI-H292
motherline.
To confirm the effect of E1A and E1B expression on the
response range, we transfected one of the clones derived
from subcloning the NCI-H292 motherline, with E1A
plus E1B. Ten E1A-positive clones differing in the level of
E1A expression were obtained (Fig 6A) and tested for IL-8
and IL-6 responses to LPS and TNF-α (Fig 6B–E). Com-
pared to E1A-negative clones, nine out of ten clones
showed a significant hyporesponsive IL-6 production to
LPS or TNF-α; the clone with the lowest E1A expression
having a normoresponsive IL-6 production. Even though
the absolute IL-6 production was much lower in E1A-pos-
itive clones, the range of IL-6 production was much larger
in the E1A-positive clones than E1A-negative clones,
showing difference of upto 130- and 3-fold, respectively.
None of the clones displayed significant hyperresponsive
IL-8 production to LPS, whereas 4 out of 10 E1A-positive
clones showed hyporesponsive IL-8 production to LPS.
Similarly, none of the clones displayed a hyperresponsive
IL-8 response to TNF-α, and 3 out of 10 clones showed a
hyporesponsive IL-8 production. In line with our previous
results, the response range for IL-8 in the E1A-positive
cells reached up to 48 for TNF-α and 23 for LPS, whereas
the control clones displayed a response range of 3.
Table 1: Number of B- and AB-clones displaying hyper- or hyporesponsive IL-8 and IL-6 production to LPS or TNF-α. Clones 
transfected with E1A plus E1B are designated AB and clones transfected with E1B are designated B. Hyperresponsive and 
hyporesponsive clones are defined respectively as clones with a significant (p < 0.05) 2.5-fold increased or 2.5-fold decreased (i.e. 0.4 
times) IL-8 or IL-6 production relative to the mean of the control (T) clones, for all tested doses of a stimulus.
Hyperresponsive Hyporesponsive
LPS TNF-α LPS TNF-α Total
IL-8 B01226
A B 22006
IL-6 B00226
A B 00134Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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IL-6 production in response to exposure to LPS and TNF-α Figure 3
IL-6 production in response to exposure to LPS and TNF-α. Equal cell numbers from clones were exposed to a con-
centration range of LPS (see z-axis; 0–1 µg/ml, A) or TNF-α (0–5 ng/ml, B) for 8 hrs. IL-6 in culture supernatant was measured 
by ELISA. T represents the mean IL-6 production (in pg/ml; y-axis) of 7 T-clones. Individual B and AB clones as designated on 
the x-axis. Statistics as described in figure 2.
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Analysis of nuclear NFκB recruitment by EMSA Figure 4
Analysis of nuclear NFκB recruitment by EMSA. Equal cell numbers from clones, indicated on the x-axis, were stimu-
lated with 0.1 µg/ml LPS (A) or 5 ng/ml TNF-α (B) for one hour, before nuclear extracts were prepared. Specific bands were 
identified by supershift using a p65 antibody for NFκB and cold oligo competition. Bands were quantified by phosphorimager 
and expressed relative to that of the stimulated T clone, which was set at one. Data represent mean ± SEM from 2 independ-
ent experiments.
IL-8 and IL-6 mRNA half-life after exposure to TNF-α Figure 5
IL-8 and IL-6 mRNA half-life after exposure to TNF-α. Equal cell numbers from clones, indicated on the x-axis, were 
stimulated with 5 ng/ml TNF-α for one hour before 5 µg/ml Actinomycin D (ActD) was added to block further transcription. 
At 0, 40 and 80 min after ActD addition, total RNA was extracted with TriZol. RNA was dot blotted and hybridized with 32P-
labelled IL-8, IL-6 and GAPDH probes. Signals were quantified on a phosphorimager and IL-8 and IL-6 mRNA levels were nor-
malized for variable loading using GAPDH mRNA levels. Half-life of the mRNA in the clones was calculated using linear regres-
sion. Data represent the mean ± SEM from 2 independent experiments (triplicate samples).Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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Expression levels of E1A protein and IL-8 and IL-6 responses of transfected NCI-H292 subclones Figure 6
Expression levels of E1A protein and IL-8 and IL-6 responses of transfected NCI-H292 subclones. A) Transfection 
of a NCI-H292 subclone yielded 10 E1A-positive clones. Expression level of E1A in the different clones was determined by 
Western blot. Exposed films were scanned and quantified. Signal is expressed in arbitrary units. Even though E1A shows as a 
single band in the printed figure, close examination of the electronic figure reveals both the 289R and the 243R E1A protein. 
Equal cell numbers from clones were exposed to a concentration series of LPS (0, 0.01, 0.1 and 1 µg/ml, 6B&D) or TNF-α (0, 
0.5 and 5 ng/ml, 6C&E) for 8 hrs. IL-8 en IL-6 concentrations in culture supernatant were measured by ELISA. E1A-negative 
clones are represented by dashed curves, E1A-positive clones by solid curves. For clarity, the clone numbers at the right are 
ranked for IL-8 and IL-6 production, and hyporesponsive clones (p < 0.05) are marked with #. Data are from one experiment 
(triplicate samples) out of two independent experiments with similar results.Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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siRNA results
To provide ultimate proof of the role of E1A protein, we
attempted to knock down E1A expression using siRNA.
Five different siRNA duplexes directed to both 12S and
13S E1A mRNA, coding for the 243R and 289R E1A
proteins [19], were generated and transfected into 4
different AB clones. As a positive control, a GAPDH siRNA
was used. Transfection of GAPDH siRNA in a final con-
centration of 4 nM resulted in a specific downregulation
of more than 90% of GAPDH mRNA, 24 h and 48 h after
transfection, indicating that both siRNA synthesis and
transfection protocols were functional. None of the siR-
NAs directed to E1A downregulated E1A mRNA at a con-
centration of 4 nM. Transfection of higher concentrations
of E1A siRNA (up to 35 nM) resulted in aspecific silencing
of both E1A and GAPDH mRNA.
We next used the shRNA DNA vector pSP-E1A (a kind gift
from Dr. David Hacker, LBTC EPFL, Lausanne, Switzer-
land) that was shown to reduce E1A mRNA by 75% in
HEK293 cells [16], but due to either a low transfection
efficiency of DNA vectors in our clones (<30%) or incom-
patibility with the U6 promoter, we could not detect
downregulation of E1A expression. To circumvent the lat-
ter, an siRNA using the same sequence was generated,
which neither knocked down E1A mRNA expression in
our clones.
Discussion
The present study aimed to investigate and extend the
hypothesis that E1A expression in lung epithelial cells,
contributes to increased IL-8 responses. We analyzed a
panel of stable transfectants expressing E1A, but we found
no uniform effect on IL-8 protein production, whereas the
effect on IL-6 production was more uniform. If anything,
clones expressing E1A displayed a much larger response
range for IL-8 than control clones, suggesting that expres-
sion of E1A dysregulates IL-8 production, leading to either
an increased or a suppressed IL-8 production. Similar
findings were obtained for E1B, indicating that the effect
is not specific for E1A.
These findings are in apparent contradiction with those
reported by Hogg et al., who described an increase in IL-8
production in E1A-expressing ras-transformed alveolar-
type II-like A549 cells as well as E1A/E1B-transformed pri-
mary bronchial epithelial cells [5,7]. In the present studies
we have used lung epithelial NCI-H292 cells, which have
been studied extensively in relation to IL-8 and IL-6 pro-
duction [9-12] and showed regulation similar to that of
other lung epithelial cell lines and primary bronchial epi-
thelial cells. For example, effects of IL-17 on TNF-α
induced IL-8 and IL-6 secretion were similar and regulated
in the same way [20]. Most importantly, post-transcrip-
tional regulation of IL-8 and IL-6 responses, which is a
major mode of regulating these responses, are directed by
various conditions to a similar extent in H292 cells and
primary cells. As NCI-H292 cells are also susceptible to
infection by many strains of adenoviruses [21], including
serotype 5, we considered NCI-H292 cells a good model
to study the effect of E1A on IL-8 and IL-6 production,
although we cannot exclude that the apparent contradic-
tory results are due to the use epithelial cells from differ-
ent origin.
E1A protein expressed in our clones was biologically
active as is evident from the reduced IL-6 production by
E1A-expressing clones (Fig 6), in line with the reported
inhibition of IL-6 gene transcription by the E1A protein
[13]. Furthermore, immunohistochemical staining of E1A
protein was restricted to the nucleus in all clones, indica-
tive of nuclear recruitment which is essential for E1A pro-
tein to display its biological activity. Despite the presence
of active E1A protein, and the relation between IL-6
responses and the expression levels of E1A, we found no
correlation between the level of E1A protein expression
and IL-8 production in the present clones. The E1A gene
encodes two primary regulators of viral and cellular gene
expression, the E1A-243R and E1A-289R proteins [19].
Distinct biological functions have been described for the
243R and 289R E1A products in mouse lung. Preferential
expression of the 243R E1A was associated with cellular
hyperplasia and low level of p53-mediated apoptosis,
whereas preferential 289R E1A expression led to pro-
apoptotic injury and acute pulmonary inflammation [22].
Our clones all expressed the 243R and 289R in an appar-
ent 1:1 ratio as detected by Western blot, however the
E1A/E1B transformed primary bronchial epithelial cells as
described by Higashimoto et al. [7] preferentially
expressed the 13S transcript coding for the 289R E1A
protein and hence may explain the observed difference. As
yet there is no data available on preferential expression of
either transcript in lung tissue of COPD patients, or in the
A549 in vitro model used by Hogg and coworkers. Other
reasons for the observed differences may arise simply
from the fact that we analyzed a larger panel of clones
which allowed us to identify the different effects or from
the cooperation of Ras with E1A in A549 cells.
Analysis of the transcriptional and post-transcriptional
mechanisms of IL-8 and IL-6 production in the various
E1A-expressing clones revealed marked heterogeneity.
There was no increased nuclear recruitment of the tran-
scription factors NFκB, AP-1 and C/EBP in E1A-positive
cells. Also, there was no change observed in the electro-
phoretic mobility of the protein-DNA complexes that
could indicate a change in the composition of the com-
plex. In fact, clone AB38 showed constitutive expression
of high levels of C/EPB activation (data not shown), and
had a high basal IL-6 production, but was not hyperre-Respiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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sponsive. The normoresponsive clone T4 showed the
highest nuclear recruitment of NFκB, but there was no
correlation between the recruitment of NFκB and the
amount of IL-8 released upon LPS stimulation. With
respect to the half-life of IL-8 mRNA, there was a similar
heterogeneity. One of the hyperresponsive clones (AB96)
had an increased stability of IL-8 mRNA, however, IL-8
mRNA in another hyperresponsive clone (AB38) had a
normal half-life. Taken together, there was no uniform
effect of E1A expression on the transcriptional and post-
transcriptional regulation of IL-8 mRNA. In fact, for some
transfectants it is unclear why they produce more IL-8 or
less IL-6, as there is no apparent effect on transcription or
mRNA degradation. An alternative explanation not
addressed in the current study is that translational control
may be affected in these transfectants.
Unexpectedly, some E1B transfectants showed similar
effects on IL-8 and/or IL-6 production to TNF-α and LPS
as E1A transfectants. This may suggest that the mere pres-
ence of adenoviral DNA or protein affects the regulation
of IL-8 and IL-6 production. A possible explanation is that
integration of vector DNA in the genome (E1A and E1B
normally co-integrate), a poorly understood process, may
affect the expression of a functional gene involved in the
cascade controlling IL-8 or IL-6 production, leading to an
altered cytokine production. The exact mechanism
remains to be determined. An approach could be to gen-
erate a panel of inducible transfectants.
The effect of E1A and E1B on the IL-8 production is prob-
ably best described by increasing the response range. Sub-
clones of the NCI-H292 mother line showed biological
variation in IL-6 and IL-8 production, giving a response
range of 15. This variation is comparable to that for NCI-
H292 clones transfected with an empty vector, but mark-
edly smaller than that for E1A plus E1B or E1B-transfected
clones. Similarly, E1A-expressing clones generated from
subclones of NCI-H292 showed an enhanced response
range for IL-8, which was at large due to reduced minimal
IL-8 production.
Ultimate proof for, or against, a role of the E1A protein in
increasing IL-8 production in lung epithelial cells would
be to knock down E1A expression using siRNA, allowed
by the short half-life (30–120 min) of the E1A protein
[23]. We generated 6 different E1A siRNAs, but none
reduced E1A mRNA or protein. GAPDH, however, was
readily downregulated by our GAPDH siRNA, validating
the method we used. The published shRNA vector driven
by the RNA polymerase-III U6 promotor, which reduced
E1A expression by 75% in HEK293 cells [16], neither
reduced E1A expression in our cells. The reason for this
failure may be due to incompatibility of the U6 promoter
with our cells. Furthermore, steric hindrance by proteins
bound to E1A mRNA in NCI-H292 cells may have pre-
vented the siRNA to bind. Hence, it remains elusive
whether the dysregulated IL-8 production comes about by
the actual viral proteins being expressed, or whether the
incorporation of the DNA is sufficient.
The question arises whether there still is a role for E1A
expression in the pathogenesis of COPD as proposed by
Hogg et al. From theirs and an other study [24] it follows
that E1A DNA and E1A protein is more abundantly
expressed in epithelial cells from COPD patients, though
the reason for increased E1A expression in COPD patients
remains elusive. Based upon our findings it is doubtful
that E1A expression per se contributes to the pathogenesis
of COPD by means of an increased IL-8 production. We
cannot exclude, however, that E1A DNA integration fol-
lowing adenoviral infection differs from that obtained
with our transfection approach. In addition, our transfec-
tion approach allowed us to analyze adenoviral integra-
tions that may be very rare events by adenoviral infection.
Indeed we found large differences in transfection effi-
ciency for the various constructs. This difference may be
explained by the cellular effect of the gene that is
expressed. As for transfection with E1A alone, there were
no viable clones expressing E1A, which we assume was
due to apoptosis. In a later study performed by Hogg et al
it was also described that with primary bronchial cells, it
is not possible to obtain clones expressing only E1A, and
that E1B expression is needed together with E1A to gener-
ate stable clones. The transfection efficiency was much
higher with the non-apoptotic E1B and empty vector. Sec-
ond, the transfection efficiency may depend on the size of
the insert in the vector. The mechanism by which a vector
integrates remains largely elusive, but in order to integrate
the vector needs to linearize, i.e. break open. The point
where the vector breaks is random, and the larger the
insert is compared to the rest of the vector, the larger the
chance that it breaks in the gene of interest, leading to a
reduction in efficiency of inserting the full gene. This may
underlie the lower efficiency of the E1A/E1B clones, as
this insert is of a similar size as the vector, and 2Kb larger
than then E1B alone. The much smaller empty vector con-
taining the Zeocyn resistance GFP tagged protein showed
the highest transfection efficiency. Furthermore, incom-
plete insertion of the E1A/E1B sequence may also lead to
expression of E1A without E1B, leading again to cell
death. As we observed some clones transfected with E1A
and E1B that were positive only for E1B, it is likely that
this also occurs.
The previously unrecognized decreased IL-6 production
by the E1A- and E1B-expressing clones, could contribute
to increased inflammation. IL-6 is regarded a pro-inflam-
matory mediator, but has also been shown to exert many
anti-inflammatory and immunosuppressive effects (seeRespiratory Research 2005, 6:111 http://respiratory-research.com/content/6/1/111
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ref. [25] for review). Moreover, in several murine models
for pulmonary inflammation IL-6 was shown to protect
against lung damage [26-29]. The reduced IL-6 produc-
tion from epithelial cells thus may play a role in the early
pathogenesis of COPD, as it is hypothesized that latent
adenoviral infection, accompanied by expression of E1A,
is established in early childhood [2]. Even though in
exhaled breath condensate of patients diagnosed with
COPD high levels of IL-6 are found [30], this IL-6 may be
derived from sources other than lung epithelial cells.
Notably, the increased IL-6 levels are observed in patients
already diagnosed with COPD, and thus do not exclude a
role for reduced IL-6 production from epithelial cells in
the early pathogenesis of COPD. Whether E1A expression
affects the expression of other genes in these transfectants
is unknown as yet.
Conclusion
Taken together, our study does not provide support for an
unique role of Ad5 E1A protein in the enhanced IL-8 pro-
duction. Expression of E1A and E1B, however, did affect
the IL-8 response to LPS and TNF-α, as was evident by the
increased response ranges, in particular due to a reduced
IL-8 production of some clones. Both E1A and E1B
reduced IL-6 production, which could play a role during
the early pathogenesis of COPD. These results warrant fur-
ther research into the impact of integrated genomic viral
sequences on inflammatory responses.
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